MAXIMIZING INVESTIGATOR MEETINGS, PHILADELPHIA, MAY 17-18, 2018
Investigator meetings are essential for successfully training clinical sites. These meetings directly affect a pharmaceutical company’s ability to collect accurate data that clearly indicates the safety and efficacy of a drug. Successful investigator meetings are often correlated to the success of Phase II/III, which are essential to new drug development. In addition to essential clinical training about the new drugs, investigator meetings can provide an in-person occasion for study participants get to know each other and form a real “team” going forward.
To train physicians and their staff on all aspects of the protocol, investigator meetings introduce the researchers to each other and the study and provide training on how to conduct the study. The program content should provide the participants with a solid understanding of the protocol: inclusion/exclusion criteria, procedures related to each visit, adverse-event reporting, lab procedures, and recruitment strategies. Most important is to communicate all this information in the most time-efficient and engaging manner. ExL’s Maximizing Investigator Meetings conference is the premier conference dedicated to developing effective and engaging investigator meetings.
Who Should Attend
This conference is designed for representatives from pharmaceutical, medical device, and biotechnology companies with responsibilities in the following areas:
Medical Science Liaison
Clinical Science Liaison
Clinical Data Management/Statistics